EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol

Gerardo Gutiérrez-Gutiérrez, Rocío Gómez-Ballesteros iD, Javier Sotoca iD, Adrián Ares, Ramón Villaverde, Virginia Reyes iD, Thaís Armangué, Elisa Salas, Paola Díaz-Abós, Pablo Rebollo, Mónica Sarmiento, Iratxe Escobar und 2 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0322168 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Gerardo Gutiérrez-Gutiérrez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital Universitario Infanta Sofía, Madrid, Spain. Hauptthemen laut MEDLINE: Myasthenia Gravis, Clinical Decision-Making. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche España.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The therapeutic landscape in generalized myasthenia gravis (gMG) has been continuously evolving in recent years, with over five products approved, each with different efficacy, safety, and administration profiles. With the availability of new targeted treatments, physicians are faced with the challenge of therapeutic decision-making tailored to traditional therapeutic goals, individual preferences, and personal experience, seeking optimal disease control with a positive safety profile. In this context of uncertainty and multiple novel choices, this study aims to provide insights into the preferred treatment choices of neurologists managing gMG and to identify demographic, professional or behavioral factors influencing the decision-making process.

Methods

This is a non-interventional, cross-sectional, web-based study involving 150 neurologists treating gMG patients in collaboration with the Spanish Society of Neurology. The primary endpoint will be to assess preferences for different gMG treatment attributes using a conjoint analysis to create hypothetical treatment scenarios. Therapeutic inertia, described as the lack of treatment initiation or intensification when therapeutic goals are not met, will be evaluated as a secondary endpoint through 7 case scenarios simulating real gMG clinical practice situations. Neurologists will also answer a survey composed of demographic, professional, and behavioral characteristics (user resistance behavior, care-related regret, burnout, risk attitude, empathy, work fulfilment, and personality traits) to recognize possible factors influencing decisions.

Conclusions

The study findings will contribute to better understanding of decision-making in gMG under a changing therapeutic landscape with multiple new targeted options, and will identify which factors have a role in affecting those decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisClinical Decision-MakingHumansCross-Sectional StudiesFemaleNeurologistsMaleSurveys and QuestionnairesAdultDecision Making

Autor:innen und Institutionen

  • Department of Neurology, Hospital Universitario Infanta Sofía, Madrid, Spain.
  • Medical Department, Roche Farma, Madrid, Spain.
  • Department of Neurology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Department of Neurology, Complejo Asistencial Universitario León, León, Spain.
  • Department of Neurology, Hospital Universitario Morales Meseguer, Murcia, Spain.
  • Department of Neurology, Hospital Regional Universitario de Málaga, Málaga, Spain.

ORCID-Profile: Rocío Gómez-Ballesteros, Javier Sotoca, Virginia Reyes

Förderung

  • Roche España

Zitieren

APA

Gutiérrez-Gutiérrez, G., Gómez-Ballesteros, R., Sotoca, J., Ares, A., Villaverde, R., Reyes, V., Armangué, T., Salas, E., Díaz-Abós, P., Rebollo, P., Sarmiento, M., Escobar, I., Maurino, J., & Querol, L. (2025). Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. PLOS One. https://doi.org/10.1371/journal.pone.0322168

Vancouver

Gutiérrez-Gutiérrez G, Gómez-Ballesteros R, Sotoca J, Ares A, Villaverde R, Reyes V, et al. Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. PLOS One. 2025. doi:10.1371/journal.pone.0322168

BibTeX
@article{GutirrezGutirrez2025,
  author = {Gutiérrez-Gutiérrez, Gerardo and Gómez-Ballesteros, Rocío and Sotoca, Javier and Ares, Adrián and Villaverde, Ramón and Reyes, Virginia and Armangué, Thaís and Salas, Elisa and Díaz-Abós, Paola and Rebollo, Pablo and Sarmiento, Mónica and Escobar, Iratxe and Maurino, Jorge and Querol, Luis},
  title = {Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0322168}
}
Kostenlos starten →